Andrew Obenshain's most recent trade in Bluebird bio Inc was a trade of 921 Common Stock done at an average price of $3.9 . Disclosure was reported to the exchange on March 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Bluebird bio Inc | Andrew Obenshain | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 3.92 per share. | 03 Mar 2025 | 921 | 18,327 (0%) | 0% | 3.9 | 3,610 | Common Stock |
| Bluebird bio Inc | Andrew Obenshain | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 763 | 19,248 (0%) | 0% | 0 | Common Stock | |
| Bluebird bio Inc | Andrew Obenshain | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 7.40 per share. | 03 Feb 2025 | 86 | 18,485 (0%) | 0% | 7.4 | 636 | Common Stock |
| Bluebird bio Inc | Andrew Obenshain | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 9.24 per share. | 06 Jan 2025 | 140 | 18,571 (0%) | 0% | 9.2 | 1,294 | Common Stock |
| Bluebird bio Inc | Obenshain Andrew | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.42 per share. | 10 Dec 2024 | 971 | 374,247 (0%) | 0% | 0.4 | 405 | Common Stock |
| Bluebird bio Inc | Andrew Obenshain | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 130,000 | 409,998 (0%) | 0% | 0 | Common Stock | |
| Bluebird bio Inc | Andrew Obenshain | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.53 per share. | 30 Sep 2024 | 34,780 | 375,218 (0%) | 0% | 0.5 | 18,270 | Common Stock |
| Bluebird bio Inc | Andrew Obenshain | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 650,000 | 650,000 | - | - | Stock Option (right to buy) | |
| Bluebird bio Inc | Andrew Obenshain | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 1.53 per share. | 01 Mar 2024 | 6,095 | 279,998 (0%) | 0% | 1.5 | 9,311 | Common Stock |
| Bluebird bio Inc | Andrew Obenshain | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.90 per share. | 05 Feb 2024 | 1,879 | 286,093 (0%) | 0% | 0.9 | 1,696 | Common Stock |
| Bluebird bio Inc | Obenshain Andrew | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 1.43 per share. | 05 Jan 2024 | 3,162 | 287,972 (0%) | 0% | 1.4 | 4,520 | Common Stock |
| Bluebird bio Inc | Andrew Obenshain | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 3.54 per share. | 10 Aug 2023 | 16,929 | 291,941 (0%) | 0% | 3.5 | 59,956 | Common Stock |
| Bluebird bio Inc | Andrew Obenshain | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 338,000 | 338,000 | - | - | Stock Option (right to buy) | |
| Bluebird bio Inc | Andrew Obenshain | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 67,600 | 308,870 (0%) | 0% | 0 | Common Stock | |
| Bluebird bio Inc | Andrew Obenshain | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.38 per share. | 01 Feb 2023 | 1,420 | 241,270 (0%) | 0% | 6.4 | 9,060 | Common Stock |
| Bluebird bio Inc | Andrew Obenshain | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 7.80 per share. | 11 Jan 2023 | 3,178 | 242,690 (0%) | 0% | 7.8 | 24,802 | Common Stock |
| Bluebird bio Inc | Andrew Obenshain | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 6.41 per share. | 04 Nov 2022 | 1,263 | 245,868 (0%) | 0% | 6.4 | 8,101 | Common Stock |
| Bluebird bio Inc | Andrew Obenshain | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 4.39 per share. | 04 Aug 2022 | 21,805 | 247,131 (0%) | 0% | 4.4 | 95,754 | Common Stock |
| Bluebird bio Inc | Andrew Obenshain | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 90,000 | 90,000 | - | - | Stock Option (right to buy) | |
| Bluebird bio Inc | Andrew Obenshain | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 18,000 | 268,936 (0%) | 0% | 0 | Common Stock | |
| Bluebird bio Inc | Andrew Obenshain | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 9.64 per share. | 10 Jan 2022 | 4,683 | 246,696 (0%) | 0% | 9.6 | 45,156 | Common Stock |
| Bluebird bio Inc | Andrew Obenshain | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 9.40 per share. | 10 Jan 2022 | 2,190 | 251,379 (0%) | 0% | 9.4 | 20,591 | Common Stock |
| Bluebird bio Inc | Andrew Obenshain | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 9.24 per share. | 10 Jan 2022 | 852 | 253,569 (0%) | 0% | 9.2 | 7,876 | Common Stock |
| Bluebird bio Inc | Andrew Obenshain | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 10.18 per share. | 07 Dec 2021 | 832 | 254,421 (0%) | 0% | 10.2 | 8,469 | Common Stock |
| Bluebird bio Inc | Andrew Obenshain | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 200,771 | 255,253 (0%) | 0% | 0 | Common Stock | |
| Bluebird bio Inc | Andrew Obenshain | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 200,000 | 401,543 | - | - | Stock Option (right to buy) | |
| Bluebird bio Inc | Andrew Obenshain | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 30,115 | 54,482 (0%) | 0% | 0 | Common Stock | |
| Bluebird bio Inc | Andrew Obenshain | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 30,000 | 60,230 | - | - | Stock Option (right to buy) | |
| Bluebird bio Inc | Andrew Obenshain | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 21,000 | 20,674 | - | - | Stock Option (right to buy) | |
| Bluebird bio Inc | Andrew Obenshain | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 18,000 | 17,721 | - | - | Stock Option (right to buy) | |
| Bluebird bio Inc | Andrew Obenshain | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 10,337 | 24,367 (0%) | 0% | 0 | Common Stock | |
| Bluebird bio Inc | Andrew Obenshain | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 9,500 | 9,353 | - | - | Stock Option (right to buy) | |
| Bluebird bio Inc | Andrew Obenshain | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 7,950 | 7,827 | - | - | Stock Option (right to buy) | |
| Bluebird bio Inc | Andrew Obenshain | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 7,000 | 6,891 | - | - | Stock Option (right to buy) | |
| Bluebird bio Inc | Andrew Obenshain | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 2,584 | 14,030 (0%) | 0% | 0 | Common Stock | |
| Bluebird bio Inc | Andrew Obenshain | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 978 | 11,446 (0%) | 0% | 0 | Common Stock | |
| Bluebird bio Inc | Andrew Obenshain | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 586 | 10,468 (0%) | 0% | 0 | Common Stock | |
| Bluebird bio Inc | Andrew Obenshain | President of SGD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2021 | 200,000 | 200,000 | - | - | Stock Option (right to buy) | |
| Bluebird bio Inc | Andrew Obenshain | President of SGD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2021 | 100,000 | 139,597 (0%) | 0% | 0 | Common Stock | |
| Bluebird bio Inc | Andrew Obenshain | President of SGD | Sale of securities on an exchange or to another person at price $ 30.75 per share. | 04 Jun 2021 | 511 | 39,597 (0%) | 0% | 30.8 | 15,715 | Common Stock |
| Bluebird bio Inc | Andrew Obenshain | President of SGD | Sale of securities on an exchange or to another person at price $ 30.14 per share. | 03 May 2021 | 29 | 40,108 (0%) | 0% | 30.1 | 874 | Common Stock |
| Bluebird bio Inc | Andrew Obenshain | President of SGD | Sale of securities on an exchange or to another person at price $ 30.21 per share. | 05 Apr 2021 | 29 | 40,137 (0%) | 0% | 30.2 | 876 | Common Stock |
| Bluebird bio Inc | Andrew Obenshain | President of SGD | Sale of securities on an exchange or to another person at price $ 29.59 per share. | 02 Mar 2021 | 34 | 40,166 (0%) | 0% | 29.6 | 1,006 | Common Stock |
| Bluebird bio Inc | Andrew Obenshain | President of SGD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Bluebird bio Inc | Andrew Obenshain | President of SGD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 15,000 | 38,884 (0%) | 0% | 0 | Common Stock | |
| Bluebird bio Inc | Andrew Obenshain | President of SGD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 2,065 | 40,949 (0%) | 0% | 0 | Common Stock | |
| Bluebird bio Inc | Andrew Obenshain | President of SGD | Sale of securities on an exchange or to another person at price $ 28.16 per share. | 16 Feb 2021 | 749 | 40,200 (0%) | 0% | 28.2 | 21,093 | Common Stock |
| Bluebird bio Inc | Andrew Obenshain | President of SGD | Sale of securities on an exchange or to another person at price $ 45.91 per share. | 02 Feb 2021 | 34 | 23,884 (0%) | 0% | 45.9 | 1,561 | Common Stock |